Skip to content

Clinical trials

Phase 4 Hypertension trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 4 Country / region: France Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20042
20053
20065
20071
20082
20091
20152

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim6
Assistance Publique - Hôpitaux de Paris2
Bristol-Myers Squibb2
Novartis Pharmaceuticals2
Centre Hospitalier Universitaire de Saint Etienne1
Collège National des Généralistes Enseignants1
Hospices Civils de Lyon1
Novartis1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Sankyo Pharma Gmbh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension20
Diabetes Mellitus, Type 22
Metabolic Syndrome2
Albuminuria1
Diabetic Nephropathies1
Essential Hypertension1
Kidney Failure, Chronic1
Proteinuria1
Sleep Apnea, Obstructive1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.